The effects of Y-25510 injection on the serum levels of some cytokines in healthy adult volunteers

European Journal of Clinical Pharmacology

Volumn 53, Issue 6, 1998, Pages 411-419

  Azuma, J ^a   Ogura, M ^b   Yamamoto, I ^a   Hisadome, M ^c   Fukuda, T ^c   Ikeda, Y ^c   Mori, H ^c   Oka, T ^c   Asano, S ^d  

^a OSAKA UNIVERSITY   (Japan)

^b Osaka Pharmacology Research Clinic   (Japan)

^c Research Laboratories   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cytokines; Y 25510

Indexed keywords

3 [4 (2 DIMETHYLAMINO 1 METHYLETHOXY)PHENYL] 1H PYRAZOLO[3,4 B]PYRIDINE 1 ACETIC ACID; ACETIC ACID DERIVATIVE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; UNCLASSIFIED DRUG; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; INTERLEUKIN DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; FEEDBACK SYSTEM; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE COUNT; LEUKOPENIA; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; BLOOD; CLINICAL TRIAL; DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; MALE; PHASE 1 CLINICAL TRIAL; REFERENCE VALUE; THROMBOCYTE; TIME; VOLUNTARY WORKER;

ADJUVANTS, IMMUNOLOGIC; ADULT; BLOOD PLATELETS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKINS; LEUKOCYTES; MALE; PYRAZOLES; PYRIDINES; REFERENCE VALUES; TIME FACTORS; VOLUNTARY WORKERS;

EID: 0031596527     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050401     Document Type: Article

References (13)

1. Hisadome M, Fukuda T, Terasawa M, Oe T, Takahata H, Goto K, Turuta S, Nomoto K (1992) Enhancement of host defense by Y-25510, ( ±)-3-[4-(2-dimethylamino-1-methylethoxy) phenyl]-1H-pyrazolo-[3,4-b]pyridine-1-acetic acid, a novel synthetic compound. A comparison with recombinant human granulocyte colony-stimulating factor in 5-fluorouracil-treated mice. Int J Immunopharmacol 14: 1195-1201
2. Nakai S, Aihara K, Hirai Y (1989) Interleukin-1 potentiates granulopoiesis and thrombopoiesis by producing hematopoietic factors in vivo. Life Sci 45: 585-591
3. Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T (1989) Interleukin 6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241-1244
4. Asano S, Okano A, Ozuwa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T, Kishimato T, Takaku F, Akiyama Y (1990) In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 75: 1602-1605
5. Hisadome M, Fukuda T, Matsuyuki H, Ikeda Y, Nomoto K (1996) Enhancement of in vivo production of IL-1α and IL-6 in mice by Y-25510, a 1H-pyrazolo-[3,4-b]pyridine-1-acetic acid derivative. Int J Immunopharmacol 18: 379-384
6. Kusuhara H, Komatsu H, Hisadome M, Ikeda Y (1997) ( ± )-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo [3, 4-b]pyridine-1-acetic acid (Y-25510) stimulates production of IL-1β and IL-6 at the level of messenger RNA expression in cultured human monocytes. Int J Immunopharmacol 18: 719-728 (1996)
7. Kitamura K, Takaku F (1989) A clinical phase study of IL-1 (abstract). Biotherapy 3: 1430-1437
8. Smith II JW, Urba WJ, Curti BD, Elwood LJ, Steis RG, Janik JE (1992) The toxic and hematologic effects of interleukin-1 alpha administrated in a phase I trial to patients with advanced malignancies. J Clin Oncol 10: 1141-1152
9. Azuma J, Kurimoto T, Awata S, Sawamura A, Yoshida H, Seto Y (1989) Phase I study of KRN 8601 (rhG-CSF) in normal healthy volunteers: safety and pharmacokinetics in single subcutaneous administration (in Japanese with English abstract). Rinsyo Iyaku 5: 2231-2252
10. Azuma J, Hamaguchi T, Seung-Eun P, Kurimoto T, Yoshida H, Seto Y, Mochizuki N, Kaneko T, Shimosaka A, Itoh H, Akahori H, Takaku F (1989) Phase I study of KRN 8601 (rhG-CSF) in normal healthy volunteers: safety and pharmacokinetics in single intravenous infusion (in Japanese with English abstract). Rinsyo Iyaku 5: 1579-1603
11. Azuma J, Tsuji S, Seung-Eun P, Yoshida H, Seto Y, Mochizuki N, Kaneko T, Shimosaka A, Itoh H, Akahori H, Mikawa K, Sasahara K, Takaku F (1989) Phase I study of KRN 8601 (rhG-CSF) in normal healthy volunteers: safety and pharmacokinetics in consecutive subcutaneous administration (in Japanese with English abstract). Rinsyo Iyaku 5: 2253-2269
12. Malefyt RDW, Abrams J, Bennett B, Figdor CG, Vries JED (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis byhuman monocytes: an autoreguratory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220
13. Fiorentino DF, Zlotnik A, Mosman TR, Howard M, O'garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822